B

BLRX

Biolinerx

3.17

0.01+0.42%
After Hours: 3.150  -0.02  -0.63%16:05 05/09 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Assets

38.91M

63.92M

76.38M

81.39M

47.29M

Total Current Assets

27.10M

47.18M

52.00M

57.40M

22.88M

Total Non Current Assets

11.80M

16.74M

24.38M

23.99M

24.41M

Total Liabilities

25.45M

50.70M

25.54M

13.30M

25.26M

Total Current Liabilities

15.41M

30.85M

10.68M

9.72M

10.64M

Total Non Current Liabilities

10.04M

19.85M

14.86M

3.58M

14.62M

Total Equity

13.46M

13.22M

50.84M

68.09M

22.03M

Total Stockholders Equity

13.46M

13.22M

50.84M

68.09M

22.03M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

38.91M

63.92M

76.38M

81.39M

47.29M

Total Common Shares Outstanding

1.34B

27.16M

23.07M

17.88M

8.73M

Total Preferred Shares Outstanding

--

--

--

--

--